Washington Trust’s GSK GSK Stock Holding History

Washington Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-80	Closed	-$3.1K	–	442
2025 Q1	$3.1K	Sell	80 -40	-33%	-$1.46K	﹤0.01%	690
2024 Q4	$4.06K	Hold	120	–	–	﹤0.01%	757
2024 Q3	$4.91K	Hold	120	–	–	﹤0.01%	740
2024 Q2	$4.62K	Hold	120	–	–	﹤0.01%	747
2024 Q1	$5.14K	Hold	120	–	–	﹤0.01%	740
2023 Q4	$4.45K	Hold	120	–	–	﹤0.01%	726
2023 Q3	$4.35K	Hold	120	–	–	﹤0.01%	700
2023 Q2	$4.28K	Hold	120	–	–	﹤0.01%	723
2023 Q1	$4.27K	Sell	120 -52	-30%	-$1.82K	﹤0.01%	739
2022 Q4	$6.04K	Buy	+172	New	+$5.73K	﹤0.01%	697
2022 Q3	–	Sell	-1,574	Closed	-$86K	–	937
2022 Q2	$86K	Buy	1,574 +40	+3%	+$2.21K	﹤0.01%	329
2022 Q1	$84K	Sell	1,534 -3,098	-67%	-$168K	﹤0.01%	354
2021 Q4	$255K	Buy	4,632 +4,232	+1,058%	+$220K	0.01%	237
2021 Q3	$19K	Hold	400	–	–	﹤0.01%	696
2021 Q2	$20K	Hold	400	–	–	﹤0.01%	691
2021 Q1	$18K	Hold	400	–	–	﹤0.01%	684
2020 Q4	$19K	Sell	400 -622	-61%	-$28.6K	﹤0.01%	665
2020 Q3	$48K	Sell	1,022 -208	-17%	-$10.4K	﹤0.01%	454
2020 Q2	$62K	Buy	1,230 +123	+11%	+$6.31K	﹤0.01%	357
2020 Q1	$53K	Buy	+1,107	New	+$59K	﹤0.01%	382
2018 Q3	–	Sell	-1,542	Closed	-$77K	–	468
2018 Q2	$77K	Buy	+1,542	New	+$77.7K	﹤0.01%	352

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Washington Trust's GSK Position: Q2 2025 in Review

Washington Trust sold out of GSK (GSK) in Q2 2025, closing a stake of 80 shares — an estimated $3.1K sold.

Washington Trust first reported a position in GSK in Q2 2018 and held it in 21 quarters. The position peaked at $255K in Q4 2021. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Washington Trust reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
Washington Trust sold 80 GSK shares in Q2 2025, an estimated $3.1K.
Washington Trust first reported a position in GSK in Q2 2018 and held it in 21 quarters.
Washington Trust's GSK position peaked at $255K in Q4 2021.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.